2026
McCutcheon RA, McGuire P, Upthegrove R, Pillinger T. Treatment resistance in first-episode psychosis. World Psychiatry. 2026 Feb;25(1):50-51. doi: 10.1002/wps.70026. PMID: 41536091; PMCID: PMC12805047.
Smith KA, Hamer-Hunt J, Kormilitzin A, Page H, Joyce DW, Cipriani A; CHRONOSIG group*. AI assisted triage of UK patients in mental health care services: a qualitative focus group study of patients’ attitudes. BMC Psychiatry. 2026 Jan 13;26(1):35. doi: 10.1186/s12888-025-07329-7. PMID: 41530772; PMCID: PMC12801542.
2025
Phillips J, Bowman E, Colli C, Handel AE, McGuire P, Blackman G. Neurological examinations for psychiatric patients: A systematic review. Schizophr Res. 2025 Oct;284:32-40. doi: 10.1016/j.schres.2025.07.008. Epub 2025 Jul 30. PMID: 40743666.
Chesney E, Oliver D, Sarma A, Lamper AD, Slimani I, Lloyd M, Dickens AM, Welds M, Kråkström M, Gasparini-Andre I, Orešič M, Lawn W, Babayeva N, Freeman TP, Englund A, Strang J, McGuire P. Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial. Neuropsychopharmacology. 2025 Nov;50(12):1759-1767. doi: 10.1038/s41386-025-02175-3. Epub 2025 Jul 24. PMID: 40702165; PMCID: PMC12518716.
Reilly TJ, Chesney E, Al-Diwani A, Jewell A, Cullen AE, Oliver D, McGuire P. Identification of menstrual psychosis cases using electronic health records. Br J Psychiatry. 2025 Jun;226(6):418-420. doi: 10.1192/bjp.2025.95. PMID: 40545260; PMCID: PMC7617820.
Malik A, Shetty H, Oliver D, Reilly TJ, Di Forti M, McGuire P, Chesney E. Cannabis Withdrawal and Psychiatric Intensive Care. JAMA Psychiatry. 2025 Aug 1;82(8):838-843. doi: 10.1001/jamapsychiatry.2025.1216. PMID: 40498495; PMCID: PMC12159852.
Tognin S, Vieira S, Oliver D, Cullen AE, Kempton MJ, Fusar-Poli P, Mechelli A, Dazzan P, Merritt K, Maat A, de Haan L, Lawrie SM, van Amelsvoort T, Arango C, Nelson B, Galderisi S, Bressan R, Kwon JS, Mizrahi R; PSYSCAN Consortium; Kahn RS, McGuire P. PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample. Schizophrenia (Heidelb). 2025 Apr 17;11(1):66. doi: 10.1038/s41537-025-00598-x. PMID: 40246889; PMCID: PMC12006469.
Aronica R, Ostinelli EG, Austin C, Oliver D, McGuire P, Brambilla P, Torous J, Cipriani A. Digital sleep phenotype and wrist actigraphy in individuals at clinical high risk for psychosis and people with schizophrenia spectrum disorders: a systematic review and meta-analysis. BMJ Ment Health. 2025 Feb 10;28(1):e301337. doi: 10.1136/bmjment-2024-301337. PMID: 39929600; PMCID: PMC11815447.
Arribas M, Barnby JM, Patel R, McCutcheon RA, Kornblum D, Shetty H, Krakowski K, Stahl D, Koutsouleris N, McGuire P, Fusar-Poli P, Oliver D. Longitudinal evolution of the transdiagnostic prodrome to severe mental disorders: a dynamic temporal network analysis informed by natural language processing and electronic health records. Mol Psychiatry. 2025 Jul;30(7):2931-2942. doi: 10.1038/s41380-025-02896-3. Epub 2025 Jan 22. PMID: 39843546; PMCID: PMC12185326.
McCutcheon RA, Keefe RSE, McGuire PM, Marquand A. Deconstructing Cognitive Impairment in Psychosis With a Machine Learning Approach. JAMA Psychiatry. 2025 Jan 1;82(1):57-65. doi: 10.1001/jamapsychiatry.2024.3062. PMID: 39382875; PMCID: PMC11465119.
Torous J, Cipriani A. A Paradigm Shift in Progress: Generative AI’s Evolving Role in Mental Health Care. JMIR Ment Health. 2025 Dec 17;12:e82369. doi: 10.2196/82369. PMID: 41405973; PMCID: PMC12710723.
Cipriani A, Ward T, Lambe S, Ostinelli EG, Blease C, Gant T, Gold SM, Holmes EA, Paccoud I, Vinnikova A, Klucken J, Uhlhaas PJ, Garcia Sanchez C, Haining K, Böge K, Lahutina S, Tomelleri L, Ryan S, Smith K, Torous J. Beyond counting clicks: rethinking engagement in digital mental health. Br J Psychiatry. 2025 Nov 24:1-3. doi: 10.1192/bjp.2025.10485. Epub ahead of print. PMID: 41277279.
Smith KA, Downs J, Robinson ESJ, Malhi GS, Potts J, Tonia T, Salanti G, Cipriani A. GALENOS approach to triangulating evidence (GATE): transforming the landscape of psychiatric research. Br J Psychiatry. 2025 Nov 7:1-6. doi: 10.1192/bjp.2025.10457. Epub ahead of print. PMID: 41199459.
Smith KA, Ward T, Lambe S, Ostinelli EG, Blease C, Gant T, Gold SM, Holmes EA, Paccoud I, Vinnikova A, Klucken J, Uhlhaas PJ, Sanchez CG, Haining K, Böge K, Lahutina S, Tomelleri L, Ryan S, Torous J, Cipriani A. Engagement and attrition in digital mental health: current challenges and potential solutions. NPJ Digit Med. 2025 Jul 2;8(1):398. doi: 10.1038/s41746-025-01778-w. PMID: 40604240; PMCID: PMC12223045.
Whiting D, Glogowska M, Mallett S, Maughan D, Lennox B, Fazel S. Use of a violence risk prediction tool (Oxford Mental Illness and Violence) in early intervention in psychosis services: mixed methods study of acceptability, feasibility and clinical role. The British Journal of Psychiatry. Published online 2025:1-10. doi:10.1192/bjp.2024.293
Seyedsalehi A, Scola G, Fazel S. Precision psychiatry: thinking beyond simple prediction models – enhancing causal predictions: commentary, Seyedsalehi et al. The British Journal of Psychiatry. Published online 2025:1-2. doi:10.1192/bjp.2025.10473
Seyedsalehi, A., Bailey, J., Ogonah, M.G.T. et al. Prediction models for self-harm and suicide: a systematic review and critical appraisal. BMC Med 23, 549 (2025). https://doi.org/10.1186/s12916-025-04367-6
Taquet M, Fazel S, Rush AJ. Transdiagnostic early warning score for psychiatric hospitalisation: development and evaluation of a prediction model. BMJ Mental Health. 2025;28:e301622. https://doi.org/10.1136/bmjment-2025-301622
Sariaslan A, Fazel S. Use of real world data to understand self-harm risk in people prescribed gabapentinoids BMJ 2025; 389 :r634 doi:10.1136/bmj.r634
2024
Chesney E, Mazibuko N, Oliver D, Minichino A, Lamper AD, Chester L, Reilly TJ, Lloyd M, Kråkström M, Dickens AM, Orešič M, Lynch E, Stoloff G, Mehta MA, McGuire P. Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD). Pharmaceutics. 2024 Dec 1;16(12):1537. doi: 10.3390/pharmaceutics16121537. PMID: 39771516; PMCID: PMC11728838.
Chesney E, Reilly TJ, Scott F, Slimani I, Sarma A, Kornblum D, Oliver D, McGuire P. Psychosis associated with cannabis withdrawal: systematic review and case series. Br J Psychiatry. 2024 Dec 3;226(5):1-12. doi: 10.1192/bjp.2024.175. Epub ahead of print. PMID: 39624030; PMCID: PMC7617269.
Oliver D, Chesney E, Cullen AE, Davies C, Englund A, Gifford G, Kerins S, Lalousis PA, Logeswaran Y, Merritt K, Zahid U, Crossley NA, McCutcheon RA, McGuire P, Fusar-Poli P. Exploring causal mechanisms of psychosis risk. Neurosci Biobehav Rev. 2024 Jul;162:105699. doi: 10.1016/j.neubiorev.2024.105699. Epub 2024 May 6. PMID: 38710421; PMCID: PMC11250118.
Oliver D, Arribas M, Perry BI, Whiting D, Blackman G, Krakowski K, Seyedsalehi A, Osimo EF, Griffiths SL, Stahl D, Cipriani A, Fazel S, Fusar-Poli P, McGuire P. Using Electronic Health Records to Facilitate Precision Psychiatry. Biol Psychiatry. 2024 Oct 1;96(7):532-542. doi: 10.1016/j.biopsych.2024.02.1006. Epub 2024 Feb 24. PMID: 38408535.
Sariaslan A, Pitkänen J, Forsman J, Kuja-Halkola R, Brikell I, et al. (2024) Risk of common psychiatric disorders, suicidal behaviours, and premature mortality following violent victimisation: A matched cohort and sibling-comparison study of 127,628 people who experienced violence in Finland and Sweden. PLOS Medicine 21(10): e1004410. https://doi.org/10.1371/journal.pmed.1004410
Ryland, H., Cook, J., Ciobanasu, O., Oluwabamise, O., Cornish, R., Al-Taiar, H., … Fazel, S. (2024). Reliability and validity of the FORUM-P and FORUM-C: two novel instruments for outcome measurement in forensic mental health. Psychology, Crime & Law, 30(2), 150–165. https://doi.org/10.1080/1068316X.2022.2076855
Fazel S, Vazquez-Montes MDLA, Lagerberg T, Molero Y, Walker J, Sharpe M, et al. Risk of repeat self-harm among individuals presenting to healthcare services: development and validation of a clinical risk assessment model (OxSET). BMJ Mental Health. 2024;27:e301180. https://doi.org/10.1136/bmjment-2024-301180
2023
McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry. 2023 May;28(5):1902-1918. doi: 10.1038/s41380-023-01949-9. Epub 2023 Jan 23. Erratum in: Mol Psychiatry. 2023 May;28(5):1919.
Coutts F, Koutsouleris N, McGuire P. Psychotic disorders as a framework for precision psychiatry. Nat Rev Neurol. 2023 Apr;19(4):221-234. doi: 10.1038/s41582-023-00779-1. Epub 2023 Mar 6. PMID: 36879033.
Joyce DW, Kormilitzin A, Smith KA, Cipriani A. Explainable artificial intelligence for mental health through transparency and interpretability for understandability. NPJ Digit Med. 2023 Jan 18;6(1):6. doi: 10.1038/s41746-023-00751-9.
Sariaslan A, Fanshawe T, Pitkänen J, Cipriani A, Martikainen P, Fazel S. Predicting suicide risk in 137,112 people with severe mental illness in Finland: external validation of the Oxford Mental Illness and Suicide tool (OxMIS). Transl Psychiatry. 2023 Apr 18;13(1):126. doi: 10.1038/s41398-023-02422-5.
Langholm C, Kowatsch T, Bucci S, Cipriani A, Torous J. Exploring the Potential of Apple SensorKit and Digital Phenotyping Data as New Digital Biomarkers for Mental Health Research. Digit Biomark. 2023 Aug 25;7(1):104-114. doi: 10.1159/000530698. PMID: 37901364; PMCID: PMC10601905.
Ralovska S, Koychev I, Marinov P, Furukawa TA, Mulsant B, Cipriani A. Brexpiprazole versus placebo or other antidepressive agents for treating depression. Cochrane Database of Systematic Reviews 2023, Issue 7. Art. No.: CD013866. DOI: 10.1002/14651858.CD013866.pub2. Accessed 01 November 2023.
Smith KA, Blease C, Faurholt-Jepsen M, Firth J, Van Daele T, Moreno C, Carlbring P, Ebner-Priemer UW, Koutsouleris N, Riper H, Mouchabac S, Torous J, Cipriani A. Digital mental health: challenges and next steps. BMJ Ment Health. 2023 Feb;26(1):e300670. doi: 10.1136/bmjment-2023-300670. PMID: 37197797; PMCID: PMC10231442.
2022
Liu Q, Salanti G, De Crescenzo F, Ostinelli EG, Li Z, Tomlinson A, Cipriani A, Efthimiou O. Development and validation of a meta-learner for combining statistical and machine learning prediction models in individuals with depression. BMC Psychiatry. 2022 May 16;22(1):337. doi: 10.1186/s12888-022-03986-0.
De Crescenzo F, D’Alò GL, Ostinelli EG, Ciabattini M, Di Franco V, Watanabe N, Kurtulmus A, Tomlinson A, Mitrova Z, Foti F, Del Giovane C, Quested DJ, Cowen PJ, Barbui C, Amato L, Efthimiou O, Cipriani A. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet. 2022 Jul 16;400(10347):170-184. doi: 10.1016/S0140-6736(22)00878-9.
McCutcheon RA, Pillinger T, Efthimiou O, Maslej M, Mulsant BH, Young AH, Cipriani A, Howes OD. Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta-analysis. World Psychiatry. 2022 Jun;21(2):287-294. doi: 10.1002/wps.20977.
